Search

Search Constraints

You searched for: Author/Creator Edelheit, Barbara

Search Results

1. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. Issue 4 (1st March 2022)

2. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. Issue 4 (1st March 2022)

3. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. Issue 4 (1st March 2022)

4. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. Issue 4 (1st March 2022)

5. A12: The Role of Serum S100A12 Protein Levels in Disease Flare After Withdrawal of Anti‐tumor Necrosis Factor Therapy in Polyarticular Forms of Juvenile Idiopathic Arthritis. Issue 11 (March 2014)

6. A12: The Role of Serum S100A12 Protein Levels in Disease Flare After Withdrawal of Anti‐tumor Necrosis Factor Therapy in Polyarticular Forms of Juvenile Idiopathic Arthritis. Issue Volume 66:Issue(2014)supplement 3 (March 2014)

7. A20: Understanding the Use and Biology of TNF Therapy in JIA—Clinical Outcomes. Issue 11 (March 2014)

8. A20: Understanding the Use and Biology of TNF Therapy in JIA—Clinical Outcomes. Issue Volume 66:Issue(2014)supplement 3 (March 2014)

9. A44: High Levels of DEK Autoantibodies May Predict Early Flare Following Cessation of Anti‐TNF Therapy. Issue 11 (March 2014)

10. A44: High Levels of DEK Autoantibodies May Predict Early Flare Following Cessation of Anti‐TNF Therapy. Issue Volume 66:Issue(2014)supplement 3 (March 2014)